How Pod Sponsorship can turn $1 into $3

by Kirsty Panting 17 Jun 2022

With the help of Pod Sponsorships, scientists at establishments like the Hudson Medical Research Institute in Melbourne can continue working on ground-breaking treatment methods for patients diagnosed with cancer.

The multiplication effect of the recent Pod Sponsorship donation from the Mike and Joan Tallis Endowment has helped support researcher Dr Carrie Van Der Weyden develop a potentially viable treatment option for patients with lymphoma cancer. Her research involves targeting a protein that is overexpressed with cutaneous T-cell lymphoma cells*. So far, this project has been successful in killing lymphoma cells in laboratory experiments and is moving towards developing a world-first clinical trial for patients with cutaneous T-cell lymphoma. Future research projects may expand on this development to help treat other forms of cancer types.

How it works:

Can Too’s Pod Sponsors fund individual training pods with a $10,000 donation. Their chosen pod is often in their local areas, fostering community connections and engagement.

Can Too participants in these pods are given twice-weekly, professionally coached training sessions, and are supported to reach a fundraising goal. 

This unique model results in the $10,000 Pod Sponsor investment being leveraged through participant fundraising to become $30-100,000 for cancer research.

We encourage our Pod Sponsors to engage with the pods, through speaking at training sessions, participating at event days and through our targeted online communications.

Optional Choice of Research Project

By request, Pod Sponsors may choose the research area or project that their multiplied donation supports. Becoming a Pod Sponsor is highly rewarding because you give Can Tooers health and fitness, the best training experience and help fund a cancer type that it meaningful for you.

To discuss how your donation can contribute to life saving cancer research, please contact paul@cantoo.org.au

* Cutaneous T-cell lymphoma (CTCL) is a rare type of cancer that begins in white blood cells called T cells (T lymphocytes). These cells normally help your body's germ-fighting immune system. In cutaneous T-cell lymphoma, the T cells develop abnormalities that make them attack the skin.

www.mayoclinic.org